Pharmacology & ToxicologybioRxivPreprint
Characterization of a KDM5 Small Molecule Inhibitor with Antiviral Activity against Hepatitis B Virus
U. Schmitz, S. A. Gilmore, D. Tam…·B. Feierbach
This study identifies a KDM5 inhibitor with anti-HBV activity in vitro but not in vivo, highlighting challenges in translating epigenetic therapies to viral infections.